Clinical Trial Update: Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants [NA]

View source ↗

Summary

A clinical trial update on using oral ibuprofen for prophylaxis of patent ductus arteriosus in extremely low birth weight infants; the current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Oral Ibuprofen Prophylaxis in Very Low Birth Weight Infants | NA | Status: UNKNOWN